SPINEMarketGroup

The spinal implant market is brimming with innovation: bioactive materials, 3D-printed devices, minimally invasive solutions, and technologies that preserve patient mobility. However, many of these innovations fail to achieve widespread clinical adoption. Why? Beyond technological development, there are two critical—and often … [Read More...] about Why Don’t Spine Innovations Reach the Operating Room?What Are the Barriers — and How Can We Overcome Them for Wider Adoption?

CARLSBAD, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced the successful completion of the first aprevo® cervical procedure on July 14, 2025 by Joseph Osorio, MD, PhD, Chief of Spine Surgery in the Department of Neurological Surgery at UC San Diego … [Read More...] about Carlsmed’s aprevo® Powers First Personalized Cervical Spine Surgery

BERN, Switzerland, July 23, 2025 (Newswire.com) - LEM Surgical, a developer of next-generation robotic technologies for hard tissue surgery, today announced two key additions to its leadership and advisory teams. Industry veteran Dave Demski has joined the company's Board of Directors, and renowned surgical technology strategist David Simon has joined the Scientific … [Read More...] about LEM Surgical Strengthens Leadership With Two Medtech Veteran Executives

INLET BEACH, FL, UNITED STATES, July 22, 2025 /EINPresswire.com/ -- Spectrum Spine Inc is pleased to announce U.S. FDA clearance of its lumbar family of cage implants. These devices incorporate BioBraille surface treatment on the bone contact areas and the interior of the graft window. The family includes PLIF/TLIF, Oblique TLIF, DLIF and ALIF procedural solutions. An ultra minimally invasive … [Read More...] about Spectrum Spine Inc Clears US FDA with Family of Lumbar Interbody Cages with BioBraille

WEST CHESTER, Pa., July 22, 2025 /PRNewswire/ -- Centinel Spine®, LLC ("the Company"), the leading global medical device company focused exclusively on treating cervical and lumbar spinal disease with the most complete and clinically-proven total disc replacement (TDR) technology platform in the world (prodisc®), today announced achievement of nearly $33 million in worldwide … [Read More...] about Centinel Spine® prodisc® Total Disc Replacement Grows 47% Worldwide in Second Quarter 2025, Setting New Revenue Record

ShareBOCA RATON, Fla.--(BUSINESS WIRE)--SurGenTec® has received additional FDA 510(k) clearance for OsteoFlo® HydroFiber™, its advanced synthetic bone graft, marking another key regulatory milestone. This expansion of indications now includes use as a bone void filler for the treatment of tumors, cysts, trauma, and osteomyelitis. This landmark clearance represents a significant advancement in the … [Read More...] about SurGenTec® Achieves Key Milestone with Expanded Indications for OsteoFlo® HydroFiber™

AUDUBON, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced that Keith Pfeil, Executive Vice President, Chief Operating Officer and Chief Financial Officer, has been appointed President and Chief Executive Officer effective July 18, 2025. Daniel Scavilla has resigned as … [Read More...] about Globus Medical Announces Leadership Transitions and Preliminary Second Quarter 2025 Sales Results

In the early 2000s, spinal implants were one of the most exciting and fastest-growing segments in the medical device industry. Advances in surgical techniques, biomaterials, and imaging led to a wave of innovation that promised to transform spinal care. Technologies for spinal fusion, disc replacement, and minimally invasive procedures opened new possibilities for both surgeons and patients. At … [Read More...] about Why Are Medical Device Giants Exiting or Losing Interest in the Spine Market?

Plano, TX, July 16, 2025 --(PR.com)-- Eminent Spine, a leading innovator in spinal implant technologies, is proud to announce a major surgical milestone: Dr. Stephen Courtney has successfully completed the world’s first spinal procedure using the company’s revolutionary 3D-printed pedicle screw system. This groundbreaking case marks a new era in spinal surgery, combining precision engineering with … [Read More...] about Dr. Stephen Courtney Performs World’s First Procedure Using Eminent Spine’s Groundbreaking 3D-Printed Pedicle Screw

PARIS and BOULDER (CO), July 16, 2025 – 6:00 pm CEST - SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announced that its patent application directed to enhance safety of bone drilling power tools thanks to a DSG-enabled active safety stop, … [Read More...] about SpineGuard obtains US patent on DSG-enabled active safety stopfor hand-held bone drilling power tools in free-hand,navigated or robotically-assisted surgery

CARLSBAD, Calif.--(BUSINESS WIRE)--Carlsmed, Inc. (“Carlsmed”), a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced the launch of its initial public offering of 6,700,000 shares of common stock. In addition, the underwriters will have a 30-day option to purchase up to 1,005,000 additional shares of common stock from Carlsmed … [Read More...] about Carlsmed Announces Launch of Initial Public Offering

BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, PEA-PME eligible), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, today announced that its innovative JAZZ range has been approved by the CFDA in China. As part of a distribution partnership signed in … [Read More...] about IMPLANET Announces CFDA Approval for Its Innovative JAZZ Range in China

AUDUBON, Pa., July 15, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the expanded Excelsius™ navigation capabilities of its next-generation oscillating system, DuraPro™, as the latest addition to the Power Portfolio, designed to advance procedural workflows through safety features and efficiency. “Our goal is to … [Read More...] about Globus Medical Introduces DuraPro™ with Navigation, a Next-Generation, Oscillating System Designed to Safeguard Delicate Tissue

BOCA RATON, Fla.--(BUSINESS WIRE)--SurGenTec®, a leading innovator in minimally invasive orthopedic and spine surgery solutions, is proud to announce the launch of its new TiLINK®-INSITE™ Sacroiliac Joint Fusion System. The system—now available in a sterile, surgery-ready kit—has already been successfully utilized in initial procedures performed across multiple U.S. sites, receiving strong … [Read More...] about SurGenTec® Launches INSITE™ Sterile Surgery-Ready Kit with Implant and Instruments for SI Joint Fusion

AUSTIN, Texas--(BUSINESS WIRE)--Wenzel Spine, Inc., a medical technology company focused on minimally invasive surgical and analytic solutions for spinal disorders, today announced it has received FDA clearance for its revolutionary expandable sacroiliac (SI) fusion implant, panaSIa. This milestone marks the first ever FDA clearance of an expandable SI fusion implant, offering a novel, … [Read More...] about Wenzel Spine Receives FDA Clearance for First Expandable Sacroiliac (SI) Fusion Implant, panaSIa™

Medtronic plc (NYSE: MDT), a global leader in medical technology, recently released its financial results for the second quarter of fiscal year 2025, which ended on April 30, 2025. This analysis covers the company’s overall performance, with a special focus on the Spine segment (Cranial & Spinal Technologies - CST), as well as market expectations and the impact on its stock price. 1. Solid … [Read More...] about Is Medtronic Back on Track After a Solid Q2 – and in Spine?

OREM, Utah, July 10, 2025 /PRNewswire/ -- Dymicron®, a privately held medical device company pioneering advanced spinal technologies, today announced that the United States (U.S.) Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval to begin a pivotal clinical study of the Triadyme®–C cervical artificial disc. This achievement marks a … [Read More...] about Dymicron Granted IDE Approval for Triadyme-C Artificial Disc